Immatics at Antibody Engineering & Therapeutics Asia (Feb 24-26) in Kyoto, Japan
Latest Science, Technology and Partners to Accelerate Antibody & Protein Therapies, ADCS, Bispecifics and Immuno-Oncology
Meet Immatics at Antibody Engineering & Therapeutics Asia in Kyoto to discuss and fast-track next-generation therapeutics for cancer patients!
Monday, Feb 24, 10.25am – 11am
Effective Targeting of Tumor-specific pMHC Targets with Bispecific T cell-engaging Receptor (TCER™) Molecules
Speaker: Dominik Maurer, VP Immunology
We are looking forward to seeing you there!
Further information on Antibody Engineering & Therapeutics Asia here.